DOMINIQUE VALLA, M. D.; NICOLE CASADEVALL, M.D.; CATHERINE LACOMBE, M.D.; BRUNO VARET, M.D.; EUGENE GOLDWASSER, M.D.; DOMINIQUE FRANCO, M.D.; JEAN-NOEL MAILLARD, M.D.; E. ALEXANDRE PARIENTE, M.D.; MICHEL LEPORRIER, M.D.; BERNARD RUEFF, M.D.; ODILE MULLER; JEAN-PIERRE BENHAMOU, M.D.
We assessed the prevalence of overt and latent primary myeloproliferative disorders in hepatic vein thrombosis. Cultures of bone marrow or peripheral blood mononuclear cells were done in 20 patients with Budd-Chiari syndrome. Erythroid colony formation in the absence of erythropoietin, which is a reliable indicator for a primary myeloproliferative disorder, was seen in 16 patients in whom Budd-Chiari syndrome was due to hepatic vein thrombosis, including 13 women aged 18 to 45 years. Among these 16 patients, the conventional criteria for the diagnosis of a primary myeloproliferative disorder were met in only 2. Primary myeloproliferative disorder, often without peripheral blood changes, is a major cause of hepatic vein thrombosis in young women.
VALLA D, CASADEVALL N, LACOMBE C, et al. Primary Myeloproliferative Disorder and Hepatic Vein Thrombosis: A Prospective Study of Erythroid Colony Formation In Vitro in 20 Patients with Budd-Chiari Syndrome. Ann Intern Med. 1985;103:329–334. doi: https://doi.org/10.7326/0003-4819-103-3-329
Download citation file:
Published: Ann Intern Med. 1985;103(3):329-334.
Gastroenterology/Hepatology, Hematology/Oncology, Liver Disease.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use